首席医疗官（CMO）
Chief Medical Officer (CMO)
关于公司：Artera 是一家领先的精准医疗公司，致力于开发人工智能检测方法，以个性化癌症治疗。Artera 提供了一种人工智能支持的检测方法，这是首款能够为局部前列腺癌患者提供预测和预后结果的检测方法：ArteraAI 前列腺检测。
Artera 的多模态人工智能（MMAI）生物标志物检测利用了一种独特的算法，该算法评估患者活检的数字图像，并从患者的临床数据中学习。ArteraAI 检测将这些信息结合起来，以确定预后并预测患者是否能从特定治疗中获益。该检测已通过多项 III 期随机试验验证，获得了 1B 级证据，并被纳入 NCCN 指南。
首席医学官（CMO）是执行领导团队的核心成员，也是公司的主要医学发言人。这位公司领导者负责制定并传达公司的医学愿景，通过识别最重要的未满足的临床需求，并确保这些需求与业务影响相一致。CMO 将塑造公司的临床战略，建立高质量数据和战略合作伙伴的强大管道，与关键意见领袖沟通，并引导组织朝着对癌症患者产生可衡量影响的创新方向发展。CMO 必须在癌症社区中具有高度的可信度和影响力，与领先的肿瘤学家和 KOL 建立信任关系，以加速采用并塑造护理标准。
该职位要求具备执业或曾任肿瘤科医生（放疗肿瘤科医生或内科肿瘤科医生）背景，深刻理解什么具有临床意义，并能将这一洞察转化为公司方向。优秀 CMO 的关键特质是他们能够制定医学战略，并带领强有力的团队执行该战略。
员工平等机会：
在 ArteraAI，我们重视汇聚来自不同背景的个体，为患者和医生开发新的创新解决方案。作为平等就业机会的雇主，我们不基于种族、肤色、宗教、国籍、年龄、性别（包括怀孕）、身体或精神残疾、健康状况、基因信息、性别认同或表达、性取向、婚姻状况、受保护的退伍军人身份或其他受法律保护的特征进行歧视。
主要职责：
愿景与战略
查看英文原文
About Us: Artera is a leading precision medicine company developing AI tests to personalize cancer therapy. Artera offers an AI-enabled test that is the first of its kind to provide both predictive and prognostic results for patients with localized prostate cancer: ArteraAI Prostate Test.
Artera’s multimodal artificial intelligence (MMAI) biomarker test leverages a unique algorithm that assesses digital images from a patient’s biopsy and learns from a patient’s clinical data. The ArteraAI test combines this information to determine prognosis and predict whether a patient will benefit from a particular therapy. The test has been validated using many Phase 3 randomized trials yielding level 1B evidence and inclusion within the NCCN guidelines.
The Chief Medical Officer (CMO) is a core member of the executive leadership team and the primary medical spokesperson for the company. This company leader is responsible for setting and communicating the medical vision for where the company should go by identifying the most important unmet clinical needs and ensuring that these align with business impact. The CMO will shape the company’s clinical strategy, build a strong pipeline of high-quality data and strategic collaborators, communicate with key opinion leaders, and guide the organization toward innovations that will make a measurable difference for cancer patients. The CMO must be a highly credible and influential voice within the cancer community, with trusted relationships among leading oncologists and KOLs that can accelerate adoption and shape standards of care.
This role requires a practicing or former oncologist (radiation oncologist or medical oncologist) who deeply understands what will be clinically impactful and can translate that insight into company direction. The defining quality of a strong CMO is their ability to craft a medical strategy and lead strong teams to execute the strategy.
Equal Employee Opportunity:
At ArteraAI, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients and physicians. As an equal opportunity employer, we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information, gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legallyprotected characteristic.
Key Responsibilities:
Vision & Strategic Direction
- Define and communicate a clear medical vision that aligns clinical opportunities with the company’s mission and commercial strategy.
- Identify and prioritize clinical unmet needs with the greatest potential for patient benefit and market impact.
- Serve as the primary medical spokesperson for the company with internal teams, investors, collaborators, and the broader oncology community.
- Anticipate shifts in oncology practice, ensuring the company is positioned ahead of the curve.
Data & Collaborator Pipeline
- Oversee strategies to build and maintain a high-quality, scalable clinical data pipeline that fuels product development, validation, and innovation.
- Cultivate a strong network of academic partners, clinical collaborators, and key opinion leaders to advance the company’s scientific and commercial goals.
- Ensure clinical evidence generation plans support both scientific credibility and payer adoption.
Cross-Functional Collaboration
- Partner closely with product, R&D, and commercial teams to integrate clinical insight into portfolio strategy.
- Translate complex clinical and scientific data into actionable business decisions.
Departmental Leadership
- Lead teams to design, execute, and interpret clinical studies that support product development and to educate the clinical impact of the test with clinicians.
- Lead team of physician leaders synthesizing collective clinical voice and expertise
Key Competencies:
- Deep understanding of oncology practice, unmet needs, and pathways to adoption
- Comes with a strong network of KOLs and research communities.
- Experienced in developing and guiding programs spanning multiple tumor types
- Visionary thinker who anticipates shifts in the clinical landscape and ensures research addresses the most impactful questions.
- Skilled and persuasive communicator who inspires confidence across clinical, scientific, and business stakeholders.
- Proven ability to build high-value partnerships and collaborative relationships to fuel a robust data pipeline as well as maintain strong relationships with influential groups, like guidelines committees.
- Decisive leader who can cut through uncertainty, guide teams with clarity, and balance scientific rigor with business priorities.
- Ensures the medical organization remains quick, nimble, and adaptable in a rapidly evolving oncology landscape
Requirements:
- 2 years of industry leadership experience
- 3 years of people and/or laboratory management experience
- Willing to travel up to 30% per month for conferences, leadership team meetings, clinician engagements